Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89

The murine cytomegalovirus protein pp89, which is encoded by gene ieI, is a nonstructural regulatory protein expressed in the immediate-early phase of the viral replication cycle and located mainly in the nucleus of infected cells. Protection of BALB/c (H-2d) mice against a lethal murine cytomegalovirus challenge infection is achieved by vaccination with a recombinant vaccinia virus, MCMV-ieI-VAC, expressing pp89 as the only murine cytomegalovirus gene product. The protection is entirely mediated by T lymphocytes of the CD8+ subset. In the present report, we analyzed the molecular basis of the recognition of pp89 by BALB/c CD8+ cytolytic T lymphocytes. A series of internal and terminal deletion mutants of gene ieI was constructed and cloned in vaccinia virus, and the antigenicity and immunogenicity of the fragments of pp89 expressed by the recombinants were studied. A region of only one-sixth of the protein, from amino acids 154 to 249 and encoded by the fourth exon of gene ieI, was sufficient for both the recognition in vitro of the protein by pp89-specific cytotoxic T lymphocytes and the induction in vivo of pp89-specific cytotoxic T lymphocytes. By using synthetic peptides, the sequence between residues 161 and 179, which is located within the defined domain, was identified as an epitope presented to BALB/C cytotoxic T lymphocytes by the class I major histocompatibility antigen Ld.

[1]  S. Jonjić,et al.  A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection , 1988, Journal of virology.

[2]  J. Whitton,et al.  Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus , 1988, Journal of virology.

[3]  Eric O Long,et al.  Structural model of HLA-DR1 restricted T cell antigen recognition , 1988, Cell.

[4]  D. Kalderon,et al.  Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen. , 1988, Virology.

[5]  J. Sissons,et al.  Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.

[6]  W. Taylor,et al.  A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.

[7]  D. Ross,et al.  T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. , 1987, Journal of immunology.

[8]  U. Koszinowski,et al.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity , 1987, Journal of virology.

[9]  S. Jonjić,et al.  Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus [published erratum appears in J Exp Med 1987 Nov 1;166(5):following 1608] , 1987, The Journal of experimental medicine.

[10]  U. Koszinowski,et al.  Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2. , 1987, Immunobiology.

[11]  N. Shastri,et al.  The Choice of T‐Cell Epitopes Utilized on a Protein Antigen Depends on Multiple Factors Distant from, as well as at the Determinant Site , 1987, Immunological Reviews.

[12]  U. Koszinowski,et al.  A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes , 1987, The Journal of experimental medicine.

[13]  U. Koszinowski,et al.  Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes , 1987, Journal of Virology.

[14]  U. Koszinowski,et al.  Sequence and structural organization of murine cytomegalovirus immediate-early gene 1 , 1987, Journal of virology.

[15]  J L Cornette,et al.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence. , 1987, Journal of immunology.

[16]  B. Dietzschold,et al.  A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2 , 1987, The Journal of experimental medicine.

[17]  U. Koszinowski,et al.  Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products , 1987, Journal of virology.

[18]  M. Gefter,et al.  Interaction of peptide antigens and class II major histocompatibility complex antigens , 1986, Nature.

[19]  U. Koszinowski,et al.  The 89,000-Mr murine cytomegalovirus immediate-early protein activates gene transcription , 1986, Journal of virology.

[20]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[21]  U. Koszinowski,et al.  Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus , 1986, Journal of virology.

[22]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[23]  S. Jonjić,et al.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs , 1985, Journal of virology.

[24]  J. Chan,et al.  Immediate causes of death in acquired immunodeficiency syndrome. , 1985, Archives of pathology & laboratory medicine.

[25]  N. Shastri,et al.  Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects , 1985, The Journal of experimental medicine.

[26]  U. Koszinowski,et al.  Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus , 1985, Journal of virology.

[27]  S. Muller,et al.  Synthetic peptides as antigens: pitfalls of conjugation methods. , 1985, Journal of immunological methods.

[28]  U. Koszinowski,et al.  Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection , 1984, Journal of virology.

[29]  U. Koszinowski,et al.  Molecular cloning and physical mapping of murine cytomegalovirus DNA , 1983, Journal of virology.

[30]  H. Grey,et al.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing , 1983, The Journal of experimental medicine.

[31]  R. Cortese,et al.  pEMBL: a new family of single stranded plasmids. , 1983, Nucleic acids research.

[32]  J. Manischewitz,et al.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.

[33]  J. Osborn Cytomegalovirus: Pathogenicity, Immunology, and Vaccine Initiatives , 1981 .

[34]  N. Flournoy,et al.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. , 1980, The Journal of infectious diseases.

[35]  H. Lemke,et al.  Fine Specificity Analysis with Monoclonal Antibodies of Antigens Controlled by the Major Histocompatibility Complex and by the Qa/TL Region in Mice , 1979, Immunological Reviews.

[36]  D. Wiley,et al.  Pillars Article: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. , 2005 .

[37]  R. Schwartz T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. , 1985, Annual review of immunology.

[38]  U. Koszinowski,et al.  Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection , 1984, Nature.

[39]  U. Koszinowski,et al.  The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage‐specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors , 1984, European journal of immunology.

[40]  J. Meyers Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention. , 1984, Birth defects original article series.

[41]  Meyers Jd Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention. , 1984 .

[42]  T. Ternynck,et al.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. , 1969, Immunochemistry.